Background. The acute respiratory distress syndrome (ARDS) occurs in patien
ts with clearly identifiable risk factors, and its treatment remains merely
supportive. We postulated that patients at risk for ARDS can be protected
against lung injury by a prophylactic treatment strategy that targets neutr
ophil-derived proteases. We hypothesized that a chemically modified tetracy
cline 3 (COL-3), a potent inhibitor of neutrophil matrix metalloproteinases
(MMPs) and neutrophil elastase (NE) with minimal toxicity, would prevent A
RDS in our porcine endotoxin-induced ARDS model.
Methods. Yorkshire pigs were anesthetized, intubated, surgically instrument
ed for hemodynamic monitoring, and randomized into three groups: (1) contro
l (n = 4), surgical instrumentation only; (2) lipopolysaccharide (LPS) (n =
4), infusion of Escherichia coli lipopolysaccharide at 100 mug/kg; and (3)
COL-3 + LPS (n = 5), ingestion of COL-3 (100 mg/kg) 12 h before LPS infusi
on. All animals were monitored for 6 h following LPS or sham LPS infusion.
Serial bronchoalveolar lavage (BAL) samples were analyzed for MMP concentra
tion by gelatin zymography. Lung tissue was fixed for morphometric assessme
nt at necropsy.
Results. LPS infusion was marked by significant (P < 0.05) physiological de
terioration as compared with the control group, including increased plateau
airway pressure (P-plat) (control = 15.7 +/- 0.4 mm Hg, LPS = 23.0 +/- 1.5
nim Hg) and a decrement in arterial oxygen partial pressure (PaO2) (LPS =
66 +/- 15 mm Hg, Control = 263 +/- 25 mm Hg) 6 h following LPS or sham LPS
infusion, respectively. Pretreatment with COL-3 reduced the above pathophys
iological changes 6 h following LPS infusion (P-plat = 18.5 +/- 1.7 rum Hg,
PaO2 = 199 +/- 35 mm Hg; P = NS vs control). MMP-9 and MMP-2 concentration
in BAL fluid was significantly increased between 2 and 4 h post-LPS infusi
on; COL-3 reduced the increase in MMP-9 and MMP-2 concentration at all time
periods. Morphometrically LPS caused a significant sequestration of neutro
phils and monocytes into pulmonary tissue. Pretreatment with COL-3 ameliora
ted this response. The wet/dry lung weight ratio was significantly greater
(P < 0.05) in the LPS group (10.1 +/- 1.0 ratio) than in either the control
(6.4 +/- 0.5 ratio) or LPS+COL-3 (7.4 +/- 0.6 ratio) group.
Conclusions. A single prophylactic treatment with COL-3 prevented lung inju
ry in our model of endotoxin-induced ARDS. The proposed mechanism of COL-3
is a synergistic inhibition of the terminal neutrophil effectors MMPs and N
E. Similar to the universal practice of prophylaxis against gastric stress
ulceration and deep venous thromboses in trauma patients, chemically modifi
ed tetracyclines may likewise be administered to prevent acute lung injury
in critically injured patients at risk of developing ARDS. (C) 2001 Academi
c Press.